Living Labs In Clinical Research: current status, challenges & future perspectives

A lot of Health and Wellbeing LLs are operating in various settings and infrastructures such as clinical setting, lab environments, distributed setting (e.g. homes, care centers) and also engaging various stakeholders from the quadruple helix in all processes. LLs also include innovative methodologies and an agile, user-centric view on designing and validating interventions.

Clinical trials are designed to answer specific questions about biomedical or behavioral interventions, including new treatments and should have clear and well-structured outcomes about efficacy, safety, efficiency, effectiveness and more and follow specific regulations. Depending on product type and development stage, investigators initially enroll volunteers or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. These are some of the questions that will be addressed during this panel.

AGENDA

10.00 – 10.05 Welcome and objectives – Despoina Petsani & Evdokimos Konstantinidis

10.05 – 10.15 The objectives of Health and Wellbeing AOTF – Panos Bamidis

10.15 – 11.05 Panel discussion moderated by HOLTEL Andreas (senior administrator

responsible for the majority of current health infrastructures projects, REA C.4)

● Jacques Demotes, Director General of the European Clinical Research Infrastructure

Network (ECRIN)

● Nico Gariboldi, Site Lead – Global Center for Digital Innovation – Senior Director at

Pfizer, Rome Area, Italy

● Ingrid Adriaensen, Businesses and Organizations innovation manager, Health Living

Labs, LicaLab, ThomasMore

● Hadas Lewy, Head of Digital Health Ventures Research, Innovation and International

Ventures Authority, Digital Medical Technology Department, Holon Institute of

Technology, Israel

● Jan-Willem van de Loo, Policy and Scientific Officer at the European Commission in charge of cancer

 

11.05 – 11.15 Q&A

SPEAKERS

Andreas Holtel

Microbial geneticist in several EU countries

Tuija Hirvikoski

Laurea University Director

Evdokimos Konstantinidis

Postdoctoral Research Associate, Thess-AHALL Researcher, AOTF Health & Wellbeing lead

Despoina Petsani

Research Assistant

Panagiotis Bamidis

Professor, Aristotle University of Thessaloniki

Nico Gariboldi

Site Lead - Global Center for Digital Innovation - Senior Director at Pfizer, Rome Area, Italy

Jacques Demotes

Director general of the European Clinical Research Infrastructure Network

Ingrid Adriaensen

LiCalab/Thomas More

Hadas Lewy

Head of Digital Health Ventures in HIT and co-founder of CARE

Jan-Willem van de Loo

Policy and Scientific Officer at the European Commission in charge of cancer,